[179 Pages Report] The global medical coatings market size is projected to grow from USD 6.0 billion in 2020 to USD 15.2 billion by 2025, at a CAGR of 20.5% during the forecast period. The growth of this market can be attributed to the rising income levels in emerging economies, a growing percentage of the geriatric population, and the increasing use of home healthcare facilities. Also, the increasing demand for minimally invasive surgical procedures is also anticipated to drive the growth of the medical coatings market.
To know about the assumptions considered Request for Free Sample Report
The medical coatings market includes major Tier I and II manufacturers like DSM, Hydromer, Surmodics, Biocoat and AST Products. These suppliers have their manufacturing facilities spread across various countries across Asia Pacific, Europe, North America, South America, and Middle East & Africa. COVID-19 has impacted their businesses as well.
The COVID-19 pandemic is spreading rapidly. 15,236,977 positive cases have been registered as of mid-July, 2020. The European Commission recently adopted a proposal on April 3, 2020, to postpone the application date of Medical Devices Regulation (MDR) for one year. The European Commission has recently approved revised harmonized standards to expedite the production of medical face masks, gloves, containers for intravenous injections, and sterilization devices and disinfectants, and alter particular requirements for emergency and transport ventilators. FDA has also issued Emergency Use Authorizations (EUA) for medical devices, including IVD test kits to diagnose COVID-19 and PPE (gloves, gowns, and masks) needed to protect healthcare providers interacting with patients.
In a minimally invasive surgery, doctors use a variety of techniques to operate with less damage to the body than with open surgery. Minimally invasive surgery is associated with less pain, a shorter hospital stay, and fewer complications. This type of surgery offers many benefits compared to traditional open surgery techniques. In many cases, it also offers a higher accuracy rate compared to traditional open surgery. The importance of less invasive medical procedures over conventional surgical procedures is increasing. The increasing prevalence of arthritis, cancer, and cardiovascular diseases, which require complex surgical treatment, has increased the demand for minimally invasive procedures. This has boosted the consumption of lightweight medical devices, such as intravascular catheters, guidewires, balloon angioplasty catheters, delivery sheaths, and implant delivery systems that can navigate through complex and sensitive parts of the body. These devices are commonly used during minimally invasive procedures in cerebrovascular, cardiovascular, and peripheral vascular systems. They often have hydrophilic and hydrophobic coatings for easy insertion of such devices into narrow vascular areas with a reduction in tissue damage. Thus, medical coatings play a major role in promoting cost efficiency and less time consumption and are highly preferred in these medical procedures. For instance, use of coatings on medical devices for cardiac and urinary catheterization procedures significantly reduces the time taken for the concerned medical or surgical procedure.
Medical coatings manufacturing entails huge up-front and continuing costs. There are many old or expired patents in this field, and medical coating developers are not allowed to develop new coatings based on past patents to avoid royalty. Hence, up-front payments are required to access expired technology. This factor is restraining the growth of this market. Eliminating all of the up-front costs and hassles is expected to enable the explosion of technology improvements. Formulation of new medical coatings involves legal wrangling, signing nondisclosure agreements, and other expenses. The rising cost of raw materials, such as silicone rubber and PTFE, are also inhibiting the medical coatings market growth to some extent.
The scope of applications of medical coatings is quite high, owing to their functional properties. There is an increasing focus on the advancements of medical devices used in treatment, mitigation, diagnosis, and prevention of diseases and abnormal physical conditions. The medical technology sector experiences continuous evolution; major focus areas are innovative imaging devices and systems, minimally invasive therapeutic products, combination device and drug/biological products, computerized devices and medical IT systems, home- and self-care products, patient monitoring systems, and artificial organs and organ-assistive products. Innovation instruments range from simple surgical instruments, such as tongue depressors and bedpans, to complex programmable pacemakers with microchip technology and laser surgical devices. Rising complexity of medical devices has led to the use of a variety of materials to manufacture these devices. However, materials used to manufacture these devices are not necessarily biocompatible and hemocompatible. To provide the desired properties to the devices, the demand for medical coatings is expected to increase. Coatings can be required to cover the entire complex structure or just part of the complex structure, and it is required to adhere to a variety of materials used within a device. Market players are developing surface treatment methods and techniques to keep up with improvements to existing substrates, as well as newly developed substrates and polymers.
The complex nature of medical devices necessitates atomic layer deposition of a coating to form a uniform layer in the targeted area of a device. Advancements in medical device designing also require the use of nanotechnology that enables deposition of multiple coating layers and helps in eliminating defects and enhance biocompatibility. Continuous developments in medical technology present an opportunity for medical coating manufacturers to develop the best solutions for critical end-use requirements.
All medical devices need to undergo design verification tests to demonstrate if they meet the specifications and, therefore, require time for approval. Regulatory bodies do not approve coatings separately. Medical OEMs have different coating materials and methodology options to choose for medical devices. The involvement of the coating supplier in the early stage of product development cycle is extremely beneficial to OEMs and can positively affect the development speed, efficiency, and cost. The coated device needs to be approved or cleared by regulatory bodies. However, some coating manufacturers perform tests on their coatings to maintain high quality. Major coating manufacturers in the market also maintain a Master File with the FDA, which shows all proprietary ingredients and processes involved with the product. A device manufacturer can incorporate this by referring to their regulatory submissions. This may save time for device development. However, the regulatory approval process remains time-consuming. The approval time varies largely according to device types. On average, the FDA takes more than three months to approve a medical device. Many coating manufacturers provide regulatory services to their customers, under which they may provide regulatory filing support and coating design requirement verification and validation process. Changes in regulations can affect medical device manufacturers as well as medical coating manufacturers. FDA regulations are likely to become more complicated and expensive in the future.
The passive coatings segment accounts for the largest share of the overall market. Hydrophilic coatings are widely used on guidewires, catheters, and introducer sheaths to lower friction coefficient. These coatings have properties such as lubricity, durability, low friction coefficient, and low particulate count. Hydrophobic coatings are water- or fluid-repellent and hence suitable for medical equipment. Minimal invasion and easy insertion of medical devices in biological openings offered by the hydrophilic coatings and excellent water repellent properties exhibited by the hydrophobic coatings are responsible for the large market size of passive medial coatings.
Polymer-based medical coatings are used in medical devices, medical equipment & tools, protective clothing, and medical implants. They are necessary to optimize durability and corrosion resistance while minimizing the coefficient of friction. Major subtypes of polymer coatings used on medical devices, medical implants, and other applications are fluoropolymers, silicone, parylene, and polyurethanes. Easy availability, low cost, optimum performance, multifunctionality, and low particulate technology are boosting the polymer-based medical coatings market.
The medical coatings market is segmented based on application into medical devices, medical implants, medical equipment & tools, protective clothing, and others. The medical devices segment accounted for the largest market share in 2019. Increased use of medical devices in the emerging economies, such as China and India, has led to the high growth of the market. The pandemic has further increased the demand for medical devices, such as catheters, guidewires, endotracheal tubes, positive pressure breathing devices, in-vitro diagnostic devices, cannulas, ventilators, ventilator accessories, infusion pumps, respirators, and other devices.
North America accounted for the largest share of the medical coatings market in 2019. Increased spending in the healthcare industry is driving the market for medical coatings in the region. The US was the largest medical coatings market in the region in 2019. Growing exports of medical devices, along with advancements in medical technology and increasing demand for home healthcare, are fueling the market in the region.
To know about the assumptions considered for the study, download the pdf brochure
The medical coatings market comprises major players such DSM (Netherlands), Hydromer (US), Surmodics (US), Biocoat (US), and AST Products (US). Hydomer is among the leading medical coatings manufacturers globally. New product launch and investment & expansion were the key strategies adopted by the company to penetrate the global medical coatings market.
Years Considered for the study
Volume (Kiloton and Ton)
Coating Type, Material Type, Application, and Region
North America, APAC, Europe, South America, and Middle East & Africa
DSM (Netherlands), Hydromer (US), Surmodics (US), Biocoat (US), AST Products (US), Total 25 major players covered
This research report categorizes the medical coatings market based on type, application, and region.
What is the current size of the global medical coatings market?
The global medical coatings market is estimated to be USD 6.0 billion in 2020 and projected to reach USD 15.2 billion by 2025, at a CAGR of 20.5%.
What are some of the regulatory authorities controlling medical coatings market?
Different countries have introduced regulations that mandate bicomapatibility and other functionalities fo medical devices.The regulatory authorities include Australian Therapeutic Goods Administration (TGA) (Australia), Health Canada (Canada), China Food and Drug Administration (China), The National Agency for the Safety of Medicines and Health Products (ANSM) (France), Federal Institute for Drugs and medical Devices (BfArM) (Germany), Medicines & Healthcare products Regulatory Agency (MHRA) (UK), US Center for Devices and Radiological Health (CDRH) (US), Food and Drugs Administration (FDA).
Who are the winners in the global medical coatings market?
Companies such as Hydromer, DSM, Surmodics, Biocoat, and AST Products fall under the winners cegory. These companies cater to the requirements of their customers by providing customized products. Moreover, these companies have multiple supply contracts with global medical device manufacturers and have effective supply chain strategies.
What is the COVID-19 impact on medical coatings manufacturers?
Industry experts believe that COVID-19 could have positive impact on medical coatings production by 15–20% globally in 2020. For instance, In April 2020, Hydromer partnered with N8 Medical for the supply of coatings to manufacture CeraShield endotracheal tubes. These tubes play a crucial role in the treatment of COVID-19 patients. This development exhibits active involvement of the company in the coatings market. The European Commission has recently approved revised harmonized standards to expedite the production of medical face masks, gloves, containers for intravenous injections, and sterilization devices and disinfectants, and alter particular requirements for emergency and transport ventilators. FDA has also issued Emergency Use Authorizations (EUA) for medical devices, including IVD test kits to diagnose COVID-19.
What are some of the technological advancements in the market?
Various research activities have been conducted by medical device manufacturers and medical coatings manufacturers across the globe to enhance passive safety systems. Companies are focused on use of nanotechnology to achieve low particulate generation and enhanced biocompatibility. For instance, Harland Medical Systems launched Lubricent Ultra Hydrophilic Coating Solution that provides superior adhesion, low particulate generation, and excellent lubricity. This product launch helped the company to offer high durability and superior lubricity coating suitable for various applications. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table Of Content
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKET SCOPE
1.2.2 REGIONS COVERED
1.2.3 YEARS CONSIDERED IN THE REPORT
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDRY DATA
188.8.131.52 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY DATA
184.108.40.206 KEY DATA FROM PRIMARY SOURCES
220.127.116.11 KEY INDUSTRY INSIGHTS
18.104.22.168 BREAKDOWN OF PRIMARY INTERVIEWS
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION/MARKET DYNAMICS
5.2 PORTER'S FIVE FORCES ANALYSIS
5.2.1 INTENSITY OF COMPETITIVE RIVALRY
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 BARGAINING POWER OF SUPPLIERS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 THREAT OF NEW ENTRANTS
5.4 AVERAGE SELLING PRICE TREND
5.5 VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM/MARKET CAP
5.7 TECHNOLOGY ANALYSIS
5.8 PATENT ANALYSIS
5.9 CASE STUDY ANALYSIS
5.8 COVID-19 IMPACT ON MEDICAL COATINGS MARKET
6 MEDICAL COATINGS MARKET, BY COATING TYPE
6.2 ACTIVE COATINGS
6.2.1 ANTIMICROBIAL COATINGS
22.214.171.124 ANTITHROMBOGENIC COATINGS
126.96.36.199 ANTI-FOG COATINGS
6.3 PASSIVE COATINGS
6.3.1 HYDROPHILLIC COATINGS
6.3.2 HYDROPHOBIC COATINGS
7 MEDICAL COATINGS MARKET, BY MATERIAL TYPE
8 MEDICAL COATINGS MARKET, BY SUBSTRATE TYPE
9 MEDICAL COATINGS MARKET, BY APPLICATION
9.2 MEDICAL DEVICES
9.3 MEDICAL EQUIPMENT & TOOLS
9.3.1 SURGIAL TOOLS
9.3.2 MEDICAL EQUIPMENT
9.4.1 Orthopedic implants
9.4.2 Cardiovascular Implants
9.4.3 Dental Tools
9.5 PROTECTIVE CLOTHING
10 MEDICAL COATINGS MARKET, BY REGION
10.2 NORTH AMERICA
10.2.1 U S
10.3.3 U K
10.3.6 REST OF EUROPE
10.4.4 SOUTH KOREA
10.4.5 REST OF ASIA-PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 SAUDI ARABIA
10.5.2 SOUTH AFRICA
10.5.4 REST OF MIDDLE EAST & AFRICA
10.6 SOUTH AMERICA
10.6.3 REST OF SOUTH AMERICA
11 COMPETITIVE LANDSCAPE
11.2 MARKET EVALUATION FRAMEWORK
11.2.1 VISIONARY LEADERS
11.2.3 DYNAMIC DIFFERENTIATORS
11.2.4 EMERGING PLAYERS
11.2.5 STRENGTH OF PRODUCT PORTFOLIO
11.2.6 BUSINESS STRATEGY EXCELLENCE
11.3 MARKET SHARE/RANKING
11.3.1 DSM BIOMEDICAL
11.3.5 AST PRODUCTS
11.4 KEY MARKET DEVELOPMENTS
11.4.1 NEW PRODUCT LAUNCH
11.4.2 INVESTMENT & EXPANSION
12 COMPANY PROFILES
(Business Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, and Recent Developments)*
12.2 SURMODICS, INC.
12.3 HYDROMER, INC
12.4 BIOCOAT INC,
12.5 SPECIALTY COATING SYSTEMS INC.
12.6 AST PRODUCTS INC.
12.7 MEDICOAT AG
12.9 SONO-TEK CORP.
12.10 PRECISION COATING CO. INC.
12.11.1 APPLIED MEDICAL COATINGS
12.11.2 FREUDENBERG MEDICAL
12.11.3 HARLAND MEDICAL SYSTEMS
12.11.4 HANGZHOU KANGSHENG
12.11.6 PPG INDUSTRIES INC.
12.11.7 WRIGHT COATING TECHNOLOGIES
12.11.8 MILLER STEPHENSON
12.11.9 SANFORD PROCESS
12.11.10 ADVANCED PLATING TECHNOLOGIES
12.11.13 ENDURA COATINGS
12.11.14 PLASTIC COATINGS
12.11.15 WALLWORK HEAT TRANSFER TECHNOLOGIES
13.1 INSIGHTS FROM INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
The study involved four major activities in estimating the current size of the medical coatings market. Exhaustive secondary research was done to collect information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.
In the secondary research process, various secondary sources, such as Hoovers, Bloomberg Businessweek, Factiva, World Bank, World Health Organization’s database, United Nations Database, and Industry Journals, were referred to for identifying and collecting information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, and databases.
The medical coatings market comprises several stakeholders, such as raw material suppliers, processors, end-product manufacturers, and regulatory organizations in the supply chain. The supply side of this market includes lab technicians, technologists, and sales managers from the medical coatings industry. On the other hand, the demand side is characterized by advancements in technology and diverse application segments. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.
Following is the breakdown of primary respondents
To know about the assumptions considered for the study, download the pdf brochure
Both the top-down and bottom-up approaches were used to estimate and validate the total size of the medical coatings market. These methods were also used extensively to determine the size of various sub-segments in the market. The research methodology used to estimate the market size included the following:
After arriving at the overall market size using the medical coatings market size estimation processes explained above, the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in various end-use industries.
With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:
Product matrix, which gives a detailed comparison of the product portfolio of each company
Benchmarking the rapid strategy shifts of the Top 100 companies in the Medical Coatings MarketRequest For Special Pricing